Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-028/KEYNOTE-28)
Clinical trial NCT02054806 · COMPLETED
Trial details
- NCT number
- NCT02054806
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-17
- Primary completion
- 2021-04-30
- Enrollment
- 477
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.